Enveda · $311M · Unknown

Enveda secured $311M to bring more nature-derived AI drugs into clinical trials. The round valued the AI biotech at $2 billion; it is currently testing drugs for skin conditions and to preserve weight loss after stopping GLP-1s.

AI-generated: summaries written by AI from the linked sources. How we use AI